These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10616547)

  • 1. A practical approach to heartburn.
    Castell DO
    Hosp Pract (1995); 1999 Nov; 34(12):89-94, 97-8. PubMed ID: 10616547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omeprazole is more effective than cimetidine in the prevention of recurrence of GERD-associated heartburn and the occurrence of underlying oesophagitis.
    Bate CM; Green JR; Axon AT; Tildesley G; Murrays FE; Owen SM; Emmas C; Taylor MD
    Aliment Pharmacol Ther; 1998 Jan; 12(1):41-7. PubMed ID: 9692699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proton pump inhibitors according to need. Always for heartburn].
    Labenz J
    MMW Fortschr Med; 2002 Jun; 144(23):34-7. PubMed ID: 12119901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity.
    Orr WC; Harnish MJ
    Aliment Pharmacol Ther; 2003 Jun; 17(12):1553-8. PubMed ID: 12823159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bronchial asthma and gastroesophageal reflux disease: are they interrelated by chance?].
    Paleev NR; Isakov VA; Ivanova OV
    Klin Med (Mosk); 2005; 83(1):9-14. PubMed ID: 15759483
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
    Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.
    Venables TL; Newland RD; Patel AC; Hole J; Wilcock C; Turbitt ML
    Scand J Gastroenterol; 1997 Oct; 32(10):965-73. PubMed ID: 9361167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soothing the burn. Management of gastroesophageal reflux disease.
    Kempf WI
    Adv Nurse Pract; 2004 Jan; 12(1):47-50. PubMed ID: 14730836
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis.
    Richter JE; Peura D; Benjamin SB; Joelsson B; Whipple J
    Arch Intern Med; 2000 Jun; 160(12):1810-6. PubMed ID: 10871975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In support of "step-up therapy" for gastroesophageal reflux disease.
    Beck IT
    Am J Gastroenterol; 2002 Feb; 97(2):503-4. PubMed ID: 11866309
    [No Abstract]   [Full Text] [Related]  

  • 12. [Heartburn: in short-term treatment you have the choice!].
    Camain JY; Wiesel PH; Peytremann-Bridevaux I
    Praxis (Bern 1994); 2012 Feb; 101(5):331-2. PubMed ID: 22377981
    [No Abstract]   [Full Text] [Related]  

  • 13. Heartburn medicine users: watch vitamin B12 levels.
    Harv Health Lett; 2014 Mar; 39(5):8. PubMed ID: 24834538
    [No Abstract]   [Full Text] [Related]  

  • 14. The ambulatory pH study is normal, but the patient is not--the importance of the symptoms index.
    Katz P
    Am J Gastroenterol; 1998 Jan; 93(1):129-31. PubMed ID: 9448198
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of gastroesophageal reflux disease.
    Pettit M
    Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
    Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
    Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination drug therapy for gastroesophageal reflux disease.
    Cross LB; Justice LN
    Ann Pharmacother; 2002 May; 36(5):912-6. PubMed ID: 11978171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
    Soto Pérez JC; Icaza ME; Vargas F; Valdovinos Díaz MA
    Rev Gastroenterol Mex; 2003; 68(2):113-9. PubMed ID: 15127647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPI use in the OTC era: who to treat, with what, and for how long?
    Inadomi JM; Fendrick AM
    Clin Gastroenterol Hepatol; 2005 Mar; 3(3):208-15. PubMed ID: 15765438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed combination of hyaluronic acid and chondroitin-sulphate oral formulation in a randomized double blind, placebo controlled study for the treatment of symptoms in patients with non-erosive gastroesophageal reflux.
    Palmieri B; Merighi A; Corbascio D; Rottigni V; Fistetto G; Esposito A
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3272-8. PubMed ID: 24379055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.